The Effect of Multidomain Dietary Education in Type 2 Diabetic Adults

Status Completed

Clinical Trial Summary

The goal of this clinical trial is to [learn about cognitive stimulation by multidomain dietary education including the dietary board game via LINE in non-dementic type 2 diabetic adults. The main questions it aims to answer are: [Question 1: Could multi-domain dietary education as cognitive stimulation improve cognitive function?] [Question 2: Could multi-domain dietary education improve dietary control belief ?] [Question 3: Could multi-domain dietary education improve health behavior?] [Question 4]: Could multi-domain dietary education improve HbA1C, and lipid profile? Participants of experimental A group will receive a video about lifestyle education 5 minutes weekly for 3 weeks, a dietary board game 10 minutes weekly for 10 weeks, and a 24-hour dietary recall record 2 times weekly for 7 weeks. And participants of the experimental B group receive the usual clinical treatment. Then experimental A and Experimental B groups will cross over 12 weeks later. Researchers will compare the effect of intervention between the experimental A group and the experimental B group.

Clinical Trial Description

Cognitive function was measured by the Saint Louis University Mental State (SLUMS) score. And we exclude the dementia group according to the SLUMS definition (<21 if the participants graduated from senior high school or above, <20 if the education level below senior high school). Experimental group A received 10-week curriculum from 1st week to 10th week, and receive d usual clinical care from 13th week to 22th week. Experimental B group received usual clinical care from 1st week to 10th week, and received 10-week curriculum from 13th week to 22th week. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05892861
Study type	Interventional
Source	National Kaohsiung Normal University
Contact
Status	Completed
Phase	N/A
Start date	June 3, 2021
Completion date	March 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04082091` - Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
Active, not recruiting	`NCT02248311` - "Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population	N/A
Completed	`NCT02653300` - A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)	Phase 2
Completed	`NCT03655535` - Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes	Phase 2
Completed	`NCT03256747` - Effects of Neuromuscular Electrical Stimulation on Glucose Variability in Patients With Type 2 Diabetes	N/A
Completed	`NCT05343767` - Investigate the Efficacy and Safety of Low-Glu in Patients Newly Diagnosed With Type II Diabetes Mellitus	N/A
Withdrawn	`NCT03675074` - Neujia Anastomosis for Treatment of Obesity and Type II Diabetes	N/A
Withdrawn	`NCT03190798` - Effects of Canagliflozin on Intravascular Volume and Hemodynamics	Phase 4
Withdrawn	`NCT03437330` - Empagliflozin Effect on Glucose Toxicity	Phase 4
Withdrawn	`NCT03008395` - Empowerment, Motivation and Medical Adherence (EMMA).	N/A
Not yet recruiting	`NCT05539066` - AI Health Assistant and Type 2 Diabetes	N/A
Completed	`NCT03682445` - Metabolic, Physical Responses To Exercise In Patients With Type 2 Diabetes Mellitus	N/A
Not yet recruiting	`NCT03239119` - The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus	Phase 3
Completed	`NCT03259789` - Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects	Phase 3
Recruiting	`NCT03506230` - Financial Incentives for Low Socioeconomic Diabetic Patients	N/A
Completed	`NCT03072407` - MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM	Phase 1
Completed	`NCT05668442` - Feasibility of an Online Exercise Community Among Individuals With Type 2 Diabetes
Completed	`NCT02956044` - Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin	Phase 1
Completed	`NCT02964572` - Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes	N/A
Completed	`NCT02628392` - A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)	N/A